Hologic Inc (HOLX) 38.51 $HOLX Research Report
Post# of 273257
Posted On: 09/03/2016 3:17:35 PM
Hologic Inc (HOLX) 38.51 $HOLX
Research Report on Medical Appliances & Equipment Equities -- Abbott Laboratories, Boston Scientific, Medtronic, and Hologic
PR Newswire - Tue Aug 30, 6:35AM CDT
The Medical Appliances and Equipment industry includes companies that manufacture medical instruments such as dental and surgical appliances. Stocks in this space tend to offer below-average dividend yields when compared to the wider market. Stock-Callers.com now reviews the recent performances of the following equities: Abbott Laboratories (NYSE: ABT), Boston Scientific Corp. (NYSE: BSX), Medtronic PLC (NYSE: MDT), and Hologic Inc. (NASDAQ: HOLX). Learn more about these stocks by accessing their free research reports at:
BSX: 24.26 (-0.07), ABT: 42.09 (-0.21), MDT: 87.32 (+0.34), HOLX: 38.51 (+0.05)
FDA Advises Zika Test for All U.S. Blood: Will Hologic Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:37AM CDT
The recent FDA recommendation allowing Hologic???s (HOLX) Procleix assay to be one of the two tests to be used in the nationwide screening will boost its test revenue growth.
DGX: 83.04 (+0.68), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
FDA expands Zika screening to all US blood centers
By MATTHEW PERRONE - AP - Fri Aug 26, 2:40PM CDT
WASHINGTON (AP) — The government told all U.S. blood banks Friday to start screening for Zika, a major expansion intended to protect the nation's blood supply from the mosquito-borne virus.
HOLX: 38.51 (+0.05)
Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
Hologic Applauds Cigna as First National Insurer to Cover Breast Tomosynthesis for Routine Breast Cancer Screening
PR Newswire - Wed Aug 24, 3:00PM CDT
Hologic Inc. (Nasdaq: HOLX) applauds Cigna's decision to cover breast tomosynthesis for routine breast cancer screening.1 Effective immediately, this new policy provides Cigna subscribers insurance coverage for Hologic's Genius(TM) 3D MAMMOGRAPHY(TM) exam, the only mammogram clinically proven to detect cancer 15 months earlier than traditional 2D screenings.2
HOLX: 38.51 (+0.05)
Research and Markets - US Market Report for Global Endometrial Ablation 2016 Featuring Hologic, Ethicon, Boston Scientific & Cooper Surgical
PR Newswire Europe - Wed Aug 24, 10:12AM CDT
DUBLIN, August 24, 2016 /PRNewswire/ --
BSX: 24.26 (-0.07), HOLX: 38.51 (+0.05)
Global Computer Aided Detection (CAD) Market to Grow Twofold to Cross US$1 bn Mark by 2024, Reports TMR
PR Newswire Europe - Wed Aug 24, 6:31AM CDT
ALBANY, New York, August 24, 2016 /PRNewswire/ --
HOLX: 38.51 (+0.05)
Global Biopsy Devices Market Worth USD 2.46 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Hologic, Cardinal Health, Cook Medical - Research and Markets
BusinessWire - Fri Aug 12, 4:50AM CDT
Research and Markets has announced the addition of the "Global Biopsy Devices Market: Trends Analysis & Forecasts to 2021" report to their offering.
HOLX: 38.51 (+0.05)
Research and Markets - United States Fluid Management Devices Market Report 2016 Featuring Olympus, Karl Storz, Richard Wolf, Stryker & Hologic
PR Newswire Europe - Wed Aug 03, 12:10PM CDT
DUBLIN, August 3, 2016 /PRNewswire/ --
HOLX: 38.51 (+0.05)
Hologic to Webcast Presentations at Upcoming Investor Conferences
PR Newswire - Tue Aug 02, 3:01PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at two upcoming investor conferences:
HOLX: 38.51 (+0.05)
National Comprehensive Cancer Network (NCCN) Includes Breast Tomosynthesis in Breast Cancer Screening and Diagnosis Practice Guidelines
PR Newswire - Mon Aug 01, 7:01AM CDT
Hologic Inc. (Nasdaq: HOLX) announced today that new guidelines published by the National Comprehensive Cancer Network (NCCN) recommend that physicians consider breast tomosynthesis exams as an option for their patients' annual breast cancer screening.1
HOLX: 38.51 (+0.05)
Upgrade Alert for Hologic (HOLX)
Comtex SmarTrend(R) - Fri Jul 29, 3:08AM CDT
Hologic (NASDAQ:HOLX) was upgraded from Hold to Buy at Evercore ISI today. The stock closed yesterday at $38.27 on volume of 4.5 million shares, below average daily volume of 5.5 million. Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.
HOLX: 38.51 (+0.05)
Hologic Rises 2.45% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jul 28, 12:54PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.62 to a high of $38.71. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $37.29 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.51 (+0.05)
After Yesterday's Rally of 2.45% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Jul 28, 12:53PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.62 to a high of $38.71. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $37.29 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.51 (+0.05)
Hologic (HOLX) Beats on Q3 Earnings, Sales; '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:29AM CDT
Hologic (HOLX) ended third-quarter fiscal 2016 on a promising note, with both its top and bottom line comfortably exceeding the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), HOLX: 38.51 (+0.05)
CVS Health (CVS) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:43PM CDT
CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
ZBH: 129.40 (+1.05), CVS: 93.84 (+0.47), BMY: 56.35 (-0.41), HOLX: 38.51 (+0.05)
Hologic Announces Financial Results for Third Quarter of Fiscal 2016
PR Newswire - Wed Jul 27, 3:01PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal third quarter ended June 25, 2016. GAAP diluted earnings per share (EPS) of $0.30 increased 200% compared to the prior year period, and non-GAAP diluted EPS of $0.51 increased 18.6%. Revenue of $717.4 million increased 3.4%, or 3.6% in constant currency terms.
HOLX: 38.51 (+0.05)
Research Report on Medical Appliances & Equipment Equities -- Abbott Laboratories, Boston Scientific, Medtronic, and Hologic
PR Newswire - Tue Aug 30, 6:35AM CDT
The Medical Appliances and Equipment industry includes companies that manufacture medical instruments such as dental and surgical appliances. Stocks in this space tend to offer below-average dividend yields when compared to the wider market. Stock-Callers.com now reviews the recent performances of the following equities: Abbott Laboratories (NYSE: ABT), Boston Scientific Corp. (NYSE: BSX), Medtronic PLC (NYSE: MDT), and Hologic Inc. (NASDAQ: HOLX). Learn more about these stocks by accessing their free research reports at:
BSX: 24.26 (-0.07), ABT: 42.09 (-0.21), MDT: 87.32 (+0.34), HOLX: 38.51 (+0.05)
FDA Advises Zika Test for All U.S. Blood: Will Hologic Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:37AM CDT
The recent FDA recommendation allowing Hologic???s (HOLX) Procleix assay to be one of the two tests to be used in the nationwide screening will boost its test revenue growth.
DGX: 83.04 (+0.68), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
FDA expands Zika screening to all US blood centers
By MATTHEW PERRONE - AP - Fri Aug 26, 2:40PM CDT
WASHINGTON (AP) — The government told all U.S. blood banks Friday to start screening for Zika, a major expansion intended to protect the nation's blood supply from the mosquito-borne virus.
HOLX: 38.51 (+0.05)
Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)
Hologic Applauds Cigna as First National Insurer to Cover Breast Tomosynthesis for Routine Breast Cancer Screening
PR Newswire - Wed Aug 24, 3:00PM CDT
Hologic Inc. (Nasdaq: HOLX) applauds Cigna's decision to cover breast tomosynthesis for routine breast cancer screening.1 Effective immediately, this new policy provides Cigna subscribers insurance coverage for Hologic's Genius(TM) 3D MAMMOGRAPHY(TM) exam, the only mammogram clinically proven to detect cancer 15 months earlier than traditional 2D screenings.2
HOLX: 38.51 (+0.05)
Research and Markets - US Market Report for Global Endometrial Ablation 2016 Featuring Hologic, Ethicon, Boston Scientific & Cooper Surgical
PR Newswire Europe - Wed Aug 24, 10:12AM CDT
DUBLIN, August 24, 2016 /PRNewswire/ --
BSX: 24.26 (-0.07), HOLX: 38.51 (+0.05)
Global Computer Aided Detection (CAD) Market to Grow Twofold to Cross US$1 bn Mark by 2024, Reports TMR
PR Newswire Europe - Wed Aug 24, 6:31AM CDT
ALBANY, New York, August 24, 2016 /PRNewswire/ --
HOLX: 38.51 (+0.05)
Global Biopsy Devices Market Worth USD 2.46 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Hologic, Cardinal Health, Cook Medical - Research and Markets
BusinessWire - Fri Aug 12, 4:50AM CDT
Research and Markets has announced the addition of the "Global Biopsy Devices Market: Trends Analysis & Forecasts to 2021" report to their offering.
HOLX: 38.51 (+0.05)
Research and Markets - United States Fluid Management Devices Market Report 2016 Featuring Olympus, Karl Storz, Richard Wolf, Stryker & Hologic
PR Newswire Europe - Wed Aug 03, 12:10PM CDT
DUBLIN, August 3, 2016 /PRNewswire/ --
HOLX: 38.51 (+0.05)
Hologic to Webcast Presentations at Upcoming Investor Conferences
PR Newswire - Tue Aug 02, 3:01PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at two upcoming investor conferences:
HOLX: 38.51 (+0.05)
National Comprehensive Cancer Network (NCCN) Includes Breast Tomosynthesis in Breast Cancer Screening and Diagnosis Practice Guidelines
PR Newswire - Mon Aug 01, 7:01AM CDT
Hologic Inc. (Nasdaq: HOLX) announced today that new guidelines published by the National Comprehensive Cancer Network (NCCN) recommend that physicians consider breast tomosynthesis exams as an option for their patients' annual breast cancer screening.1
HOLX: 38.51 (+0.05)
Upgrade Alert for Hologic (HOLX)
Comtex SmarTrend(R) - Fri Jul 29, 3:08AM CDT
Hologic (NASDAQ:HOLX) was upgraded from Hold to Buy at Evercore ISI today. The stock closed yesterday at $38.27 on volume of 4.5 million shares, below average daily volume of 5.5 million. Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.
HOLX: 38.51 (+0.05)
Hologic Rises 2.45% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jul 28, 12:54PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.62 to a high of $38.71. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $37.29 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.51 (+0.05)
After Yesterday's Rally of 2.45% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Jul 28, 12:53PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.62 to a high of $38.71. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $37.29 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.51 (+0.05)
Hologic (HOLX) Beats on Q3 Earnings, Sales; '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:29AM CDT
Hologic (HOLX) ended third-quarter fiscal 2016 on a promising note, with both its top and bottom line comfortably exceeding the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), HOLX: 38.51 (+0.05)
CVS Health (CVS) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:43PM CDT
CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
ZBH: 129.40 (+1.05), CVS: 93.84 (+0.47), BMY: 56.35 (-0.41), HOLX: 38.51 (+0.05)
Hologic Announces Financial Results for Third Quarter of Fiscal 2016
PR Newswire - Wed Jul 27, 3:01PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal third quarter ended June 25, 2016. GAAP diluted earnings per share (EPS) of $0.30 increased 200% compared to the prior year period, and non-GAAP diluted EPS of $0.51 increased 18.6%. Revenue of $717.4 million increased 3.4%, or 3.6% in constant currency terms.
HOLX: 38.51 (+0.05)
(0)
(0)Scroll down for more posts ▼